Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Controlled Study of the Safety and Tolerability of the Live Cell-based Vaccine Against Smallpox and Other Orthopoxvirus Infections (VAC∆6 Vaccine) Based on Vaccinia Virus, in Volunteers Aged 18-40 Years

NCT05762523 is registered in ClinicalTrials.gov with Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" as lead sponsor.

NCT NCT05762523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05762523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Controlled Study of the Safety and Tolerability of the Live Cell-based Vaccine Against Smallpox and Other Orthopoxvirus Infections (VAC∆6 Vaccine) Based on Vaccinia Virus, in Volunteers Aged 18-40 Years
Lead sponsor
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"
Phase
Phase 1
Overall status
Completed
Start date
May 18, 2019
Completion date
January 27, 2020
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cowpox, monkeypox, smallpox, vaccinia virus infection